Literature DB >> 4289539

Infusion chemotherapy in hepatoma and metastatic liver tumors.

B Gorgun, A L Watne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4289539     DOI： 10.1016/0002-9610(67)90280-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  7 in total

1.  Intraarterial hepatic chemotherapy with fluorouracil, fluorodeoxyuridine, mitomycin C, cisplatin or methotrexate as single-agent anticancer drugs for a transplanted experimental liver tumor in rats.

Authors:  S Kurth; D Bulian; B Kreft; T Riemenschneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Low-dose methotrexate therapy for hepatoblastoma.

Authors:  S D Weitman; G J Kato; J L Barbosa; B A Kamen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Infusion of liver tumours.

Authors: 
Journal:  Br Med J       Date:  1968-08-10

4.  One shot administration of antineoplastic agents in massive doses via the celiac artery for inoperable cancer of the liver.

Authors:  Y Kinami; M Hirose; O Takamatu
Journal:  Jpn J Surg       Date:  1972-09

5.  Hepatic artery infusion chemotherapy in hepatoma.

Authors:  J L Provan; J F Stokes; D Edwards
Journal:  Br Med J       Date:  1968-08-10

6.  Inhibition of the growth of human hepatocellular carcinoma in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717.

Authors:  N J Curtin; A L Harris; O F James; M F Bassendine
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

7.  Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?

Authors:  Do Young Kim
Journal:  Clin Mol Hepatol       Date:  2017-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.